Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q2 FY2026 Earnings Presentation
46 slides from Balaji Amines's earnings presentation, Nov 12, 2025
Slide 1: Exchange filing letter for Q2FY26 investor presentation
12th November, 2025 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Ban
Slide 2: Investor Presentation – November 2025
Investor Presentation – November 2025
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 3
Slide 5: Q2FY26: Financial Highlights
Q2FY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin 20 20 18 326 327 316 64 64 40 40 12 12 57 31 10 Q2FY25 Q1FY26 Q2FY26 Q2FY25 Q1FY26 Q2FY26 Q2FY25 Q1FY26 Q2FY26 Q2FY25 Q1FY26 Q2FY26 EBITDA Margin PAT Margin Consolidated Revenue EBITDA PAT EBITDA & PAT Margin
Slide 6: H1FY26: Financial Highlights
H1FY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin -3% 19 19 -5% -12% 664 643 128 121 81 12 71 11 H1FY25 H1FY26 EBITDA Margin H1FY25 H1FY26 H1FY25 H1FY26 H1FY25 H1FY26 PAT Margin Consolidated Revenue EBITDA PAT EBITDA & PAT Margin -5% -9% -15% 19 18 749 715 1
Slide 7: Q2 FY26 - Consolidated Performance Highlights
Q2 FY26 - Consolidated Performance Highlights Revenue from Operations for Q2FY26 stood at ₹ 341 crore, as compared to ₹ 358 crore in Q1FY26, indicating a stable operational performance. Volumes were maintained at similar levels in comparison to Q2FY25, supported by stable commodity prices and consis
Slide 8: New Project Highlights (1/2)
New Project Highlights (1/2) Update on New Projects Commissioned and New Proposed Products/Projects: • DME Plant at Unit-IV. The Plant is expected to be commissioned during the FY 2025-26. This has an application in the Aerosol industry apart from using it as a replacement to LPG for Industrial and
Slide 9: New Project Highlights (2/2)
New Project Highlights (2/2) New expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited • Investment is being made for wide range of products, including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) 30%(Solution), Sodium Cyanide (NaCN) 100%(Solid), Ethylene Diamine Tetra Acetic A
Slide 10: Expansion Plans
Expansion Plans EXECUTED ON SCHEDULE (Methylamines) IN PROGRESS (Dimethyl Ether) • Market Leader in Methylamines production in India with installed capacity of • Dimethyl Ether (DME) with a Capacity of 1,00,000 tons per annum under Phase-3 48,000 TPA being increased to 88,000 TPA expansion a new age
Slide 11: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q2FY26 Q2FY25 Y-o-Y Q1FY26 Q-o-Q H1FY26 H1FY25 Y-o-Y Total Revenue 316 326 -3% 327 -3% 643 664 -3% Raw Material 177 176 181 357 363 Employee expense 18 18 19 37 35 Other expenses 65 68 63 128 138 EBITDA 57 64 -11% 64 -11%
Slide 12: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q2FY26 Q2FY25 Y-o-Y Q1FY26 Q-o-Q H1FY26 H1FY25 Y-o-Y Total Revenue 348 356 -2% 367 -5% 715 749 -5% Raw Material 185 188 212 397 405 Employee expense 19 19 20 40 38 Other expenses 76 79 71 147 161 EBITDA 67 70 -4% 64 5%
Slide 13: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement ASSETS (in Rs. Crore) Sep-25 Mar-25 EQUITY AND LIABILITIES (in Rs. Crore) Sep-25 Mar-25 (1) NON-CURRENT ASSETS EQUITY (a) Equity Share capital 6.5 6.5 (a) Property, plant & equipment 885.0 827.9 (b) Other equity 1684.4 1648.7 (b) Capital work-in-progress 137.3 151.
Slide 14: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement ASSETS (in Rs. Crore) Sep-25 Mar-25 EQUITY AND LIABILITIES (in Rs. Crore) Sep-25 Mar-25 EQUITY (1) NON-CURRENT ASSETS (a) Equity Share capital 6.5 6.5 (a) Property, plant & equipment 1049.4 998.1 (b) Other equity 1875.5 1838.6 (b) Capital work-in-progress 339.2 2
Slide 15: Standalone Cash Flow Statement
Standalone Cash Flow Statement Cash Flow Statement (in Rs. Crore) Sep-25 Sep-24 Profit before Tax 97.4 109.1 Adjustment for Non-Operating Items 16.8 13.6 Operating Profit before Working Capital Changes 114.1 122.7 Changes in Working Capital 60.0 0.5 Cash Generated from Operations 54.1 122.2 Less: Di
Slide 16: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement (in Rs. Crore) Sep-25 Sep-24 Profit before Tax 100.6 118.4 Adjustment for Non-Operating Items 21.8 15.9 Operating Profit before Working Capital Changes 122.5 134.3 Changes in Working Capital 84.8 -81.7 Cash Generated from Operations 37.7 215.9 Les
Slide 17: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 16
Slide 18: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential Globally, ~61% of aliphatic amines and Top six companies control around 50% of In terms of the usage, Aliphatic Amines The Amines Market is projected to grow amine-based chemicals get consumed in the global capacities. China is the
Slide 19: Balaji Amines – Pioneers in Amines & Specialty Chemicals
Balaji Amines – Pioneers in Amines & Specialty Chemicals Forward integrated suite of products 50+ 40+ State-of-the-art manufacturing facilities fully equipped with Downstream products added based on strength of amine manufacturing which have value addition latest DCS technology Countries Product bas
Slide 20: Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals
Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals Particulars Amines Amine Derivatives Specialty & Other Chemicals o Aliphatic Amines find increasing consumption o Amine Derivatives are used to make further salts and applications in a Chemically mature Industry and other complex c
Slide 21: Robust Manufacturing Backbone with Scalable Capacities
Robust Manufacturing Backbone with Scalable Capacities Existing Installed Capacity Proposed Capacity Total Capacity after Product Application Areas (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMA
Slide 22: Well-Positioned Across Essential and Evolving Industries
Well-Positioned Across Essential and Evolving Industries Industry Wise - Revenue Breakup 3% 4% 3… 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others Investor Presentation 21
Slide 23: Expanding Global Footprint Across Key Export Markets
Expanding Global Footprint Across Key Export Markets • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatemala • South Africa
Slide 24: Trusted by Industry Leaders Across the Globe
Trusted by Industry Leaders Across the Globe Amines Amine Derivatives Specialty & Other Chemicals Investor Presentation 23
Slide 25: Integrated Value Chain Enhancing Operational Resilience
Integrated Value Chain Enhancing Operational Resilience Value-Added Products Robust Logistics Capabilities Preference for Local Sourcing Exposure to pharma sector Capex towards high-value Efficient logistics ensures safe Safety is a critical factor and Extensive usage in solvents led to derivatives
Slide 26: Distinctive Strengths Powering Our Competitive Edge
Distinctive Strengths Powering Our Competitive Edge Extensive Geographical Presence Market Leadership and Unique Positioning Strategic manufacturing footprint and global supply chain ensure Largest manufacturer of Aliphatic Amines unmatched market responsiveness, cost-efficient logistics, and in Ind
Slide 27: Focused Strategy to Enhance Value Across the Value Chain
Focused Strategy to Enhance Value Across the Value Chain Target fast growing industries Value Added Products Cater to fast growing industries, namely, Focus towards high-value derivatives and pharmaceuticals, agro-chemicals, refineries, specialty chemicals with an aim to move up water treatment, rub
Slide 28: Poised for the Next Phase of Scalable, Profitable Growth (1/2)
Poised for the Next Phase of Scalable, Profitable Growth (1/2) Project Accorded Mega Strategically Located Plant Product Profile Balaji Specialty Chemicals Project Status Environmental clearance received In Phase-1 of Greenfield Project Electronic Grade DMC Existing Maharashtra’s Energy and Labour f
Slide 29: Poised for the Next Phase of Scalable, Profitable Growth (2/2)
Poised for the Next Phase of Scalable, Profitable Growth (2/2) New Products = First High Demand for Products Solar Power Plant Mover advantage Significant opportunity exists to The demand of Methylamines has The 20 MW Greenfield Solar Power introduce new products & gain First increased in India. Hig
Slide 30: About Balaji Speciality Chemicals
About Balaji Speciality Chemicals 01 02 03 Balaji Speciality Chemicals Limited (BSCL) is Commenced its commercial operations in June 2019 from Manufacturing products such as Ethylene Diamine (EDA), BAL owns 55% in subsidiary Balaji Speciality Chemicals its state of-the-art manufacturing facility in
Slide 31: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel o Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur o Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity o Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 32: Balaji Sarovar Premiere – Q2FY26 Operating Matrix
Balaji Sarovar Premiere – Q2FY26 Operating Matrix Constitutes Rs725 Lakhs 4,674 129 Rooms 2.30% of from Hotel Division Rs. ARR Total Revenue Business 70% Rs. 3,268 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ADR: Average Daily Rate RevPAR: Revenue per Available Room Investo
Slide 33: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 32
Slide 34: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 1,430 379 353 244 232 265 159 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31
Slide 35: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY25 FY24 Consolidated Debt 11 20 During the year the following plants have been commissioned 1) Methylamines Plant Consolidated Networth 2018 1893 2) N-Butylamine Plant – Unit IV 3) Rooftop Solar Power Plants at various units Total Capital Employed 20
Slide 36: Consistent Dividend Payout
Consistent Dividend Payout 550% 550% 500% 300% 200% 160% FY20 FY21 FY22 FY23 FY24 FY25 Particulars (Rs. per share) FY20 FY21 FY22 FY23 FY24 FY25 Consolidated Book Value 206 281 406 524 584 623 Consolidated EPS 32 74 114 100 63 49 Dividend 3.20 4.00 6.00 10.00 11.00 11.00 Investor Presentation 35
Slide 37: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 36
Slide 38: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily Unit 4: Increased Unit 4 : Capex for Phase 2 & 3 of Greenfield Capex to be capacity utilization & 1 Capex Phase - 2 & 3 completed till FY 2026 2 capacity additions of Higher capacity utilization of new Ethylamines plant Phase - 1 capex Dimethyl Ether (DME) pl
Slide 39: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Prathap Reddy Mr. N. Rajeshwar Reddy Executive Chairman Whole Time Director • Civil Engineer by Education. Incorporated BAL in 1988 • Commerce Graduate having over 48 years of • BAL's continuing success is a testimony to his experience across industries entr
Slide 40: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Three Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP Certifica
Slide 41: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities Mahatma Award for Sustainable “Company of the Year” in International Tourism & Product Innovator of the Year in Distinguished Contribution in the Excellent CSR in Water and Responsible Business Chemicals at FICCI Chemicals Hospitality Award For
Slide 42: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On October 8, 2025, Balaji Amines Limited bagged the Western Zone Award in the Large Scale Enterprise category for its outstanding work in the Healthcare sector. The award was received by Mr. Arun Masal, General Manager – Finance, and Mr. Vinod
Slide 43: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre
Slide 44: ESG & CSR Initiatives
ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur University, Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay Gotewadi, Mohol, Solapur dt. 10.12.2024 Penur,Mohol, Solapur dt 07.06.2024 Solapur dt.09.10.2024 Constructed
Slide 45: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Bhimgal, Construction of Toilet Block at Indira Kale Prashala, Jalkotwadi, dt. Distributed Sanitary Napkin Incinerator and Vending Machine at Nizamabad, dt. 04.01.2025 25.03.2025 Vishwabhushan Vidyalay, Solapur dt.30.09.2024
Slide 46: THANK YOU
Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 cs@balajiamines.com Email - cs@balajiamines.com www.balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Nikunj